Ibrutinib and Rituxan for Chronic GVHD

NCT04235036 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Low Recruitment

Conditions

Graft Vs Host Disease

Interventions

DRUG: Rituximab
DRUG: Ibrutinib

Sponsor

Northside Hospital, Inc.

Collaborators

[object Object]